EX-4.1



 



Exhibit
4.1



INVESTOR RIGHTS AGREEMENT




     INVESTOR RIGHTS AGREEMENT dated as of July 23, 2007 by and among The Princeton Review, Inc., a
Delaware corporation (the “Company”), the persons executing this Agreement as Purchasers (the
“Purchasers”), and the persons executing this Agreement as Common Stockholders (the
“Stockholders”).



     WHEREAS, the Company and the other parties hereto wish to provide certain arrangements with
respect to the registration of shares of common stock, $.01 par value, of the Company (the “Common
Stock”) under the Securities Act (as defined below);



     WHEREAS, the Stockholders are holders of shares of Common Stock;



     WHEREAS, the Company and the Purchasers have entered into a Series C Preferred Stock Purchase
Agreement, dated the same date as this Agreement (the “Purchase Agreement”), pursuant to which the
Company is issuing and selling to the Purchasers, and the Purchasers are purchasing from the
Company, an aggregate of up to 60,000 shares of the Company’s Series C Convertible Preferred Stock,
par value $.01 per share (the “Series C Preferred Stock”);



     WHEREAS, it is a condition to the obligations of certain of the Purchasers under the Purchase
Agreement that this Agreement be executed by the parties hereto, and the parties are willing to
execute this Agreement and to be bound by the provisions hereof; and



     NOW THEREFORE, for good and valuable consideration; the receipt and adequacy of which is
hereby acknowledged by the parties, the parties hereby agree as follows:



     1. Certain Definitions. As used in this Agreement, the following terms shall have the
following respective meanings:



     “Certificate of Designation” shall mean the Certificate of Designation setting forth the
rights, preferences and privileges of the Series C Preferred Stock, filed in accordance with the
Purchase Agreement.



     “Commission” shall mean the Securities and Exchange Commission, or any other federal agency at
the time administering the Securities Act.



     “Conversion Shares” shall mean shares of Common Stock issued or issuable upon conversion of
the Series C Preferred Stock.



     “Equity Securities” shall mean any (i) Common Stock or preferred stock of the Company, (ii)
any security convertible, with or without consideration, into any Common Stock, preferred stock or
other security (including debt securities convertible into capital stock of the Company and any
option to purchase such a convertible security), (iii) any security carrying any



-1-









 




warrant or right to subscribe to or purchase any Common Stock, preferred stock or other security, or (iv) any such
warrant or right.




     “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, or any similar
federal statute, and the rules and regulations of the Commission thereunder, all as the same shall
be in effect at the time.



     “Fully Diluted Basis” means, for the purposes of determining the number of shares of Common
Stock outstanding, a basis of calculation which takes into account (a) shares of Common Stock
actually issued and outstanding at the time of such determination, and (b) that number of shares of
Common Stock that is then issuable upon conversion of all then outstanding shares of Series C
Preferred Stock.



     “Investors” shall mean the Stockholders and the Purchasers party to this Agreement.



     “Preferred Shares” shall mean shares of Series C Preferred Stock issued to the Purchasers
pursuant to the Purchase Agreement.



     “Pro Rata Share” of any Purchaser means the ratio of (a) the number of shares of Common Stock
beneficially owned by such Purchaser plus the number of shares of Common Stock issuable upon
conversion of the Series C Preferred Stock beneficially owned by such Purchaser immediately prior
to the issuance of any Equity Securities to (b) the total number of shares of the Company’s Common
Stock outstanding on a Fully Diluted Basis, immediately prior to the issuance of such Equity
Securities.



     “Purchaser Permitted Transferee shall mean any affiliate of a Purchaser or any entity or
investment vehicle, including a partnership, in which a Purchaser and/or its affiliates has a
majority economic interest or which is managed by a Purchaser or any of its affiliates.



     “Registrable Common Stock” shall mean shares of Common Stock (other than Conversion Shares)
held by Investors or Purchaser Permitted Transferees, excluding shares of Common Stock which (a)
have been registered under the Securities Act pursuant to an effective registration statement filed
thereunder and disposed of in accordance with the registration statement covering them, or (b) have
been publicly sold pursuant to Rule 144 under the Securities Act; provided,
however, that all shares of Common Stock held by any Investor shall cease to be Registrable
Common Stock when such Investor is able to sell all shares of Common Stock held by such Investor
pursuant to Rule 144 under the Securities Act in a three-month period.



     “Registration Expenses” shall mean the expenses so described in Section 5.



     “Registrable Stock” shall mean Registrable Common Stock and Restricted Stock.



-2-









 





     “Restricted Stock” shall mean the Conversion Shares, excluding Conversion Shares which have
been (a) registered under the Securities Act pursuant to an effective registration statement filed
thereunder and disposed of in accordance with the registration statement covering them or (b)
publicly sold pursuant to Rule 144 under the Securities Act.



     “Securities Act” shall mean the Securities Act of 1933, as amended, or any similar federal
statute, and the rules and regulations of the Commission thereunder, all as the same shall be in
effect at the time.



     “Selling Expenses” shall mean the expenses so described in Section 5.



     2. Demand Registration Rights. (a) At any time following the date hereof, the
holders of Restricted Stock constituting at least twenty percent (20%) of the total shares of
Restricted Stock then outstanding may request the Company to register under the Securities Act all
or any portion of the shares of Restricted Stock held by such requesting holder or holders for sale
in the manner specified in such notice, provided that the aggregate offering price, as such
amount is determined on the cover page of the registration statement, shall not be less than
$2,500,000. Such request shall specify the intended method of disposition thereof by such holder
or holders, including whether (i) the registration requested is for an underwritten offering and
(ii) the registration statement covering such Restricted Stock shall be a “shelf” and provide for
the sale by the holder or holders thereof of the Restricted Stock from time to time on a delayed or
continuous basis under Rule 415 under the Securities Act. For purposes of this Section 2 and
Sections 5, 11(a) and 11(d), the term “Restricted Stock” shall be deemed to include the number of
shares of Restricted Stock which have been issued to or would be issuable to a holder of Preferred
Shares upon conversion of all Preferred Shares held by such holder at such time, provided,
however, that the only securities which the Company shall be required to register pursuant
hereto shall be shares of Common Stock, and provided, further, however,
that, in any underwritten public offering contemplated by this Section 2 or Section 3, the holders
of Preferred Shares shall be entitled to sell such Preferred Shares to the underwriters for
conversion and sale of the shares of Common Stock issued upon conversion thereof. In the event
that any registration pursuant to this Section 2 shall be, in whole or in part, an underwritten
public offering of Common Stock, the number of shares of Restricted Stock to be included in such an
underwriting may be reduced (pro rata among the requesting holders based upon the number of shares
of Restricted Stock beneficially owned by such holders) if and to the extent that the managing
underwriter shall be of the opinion that such inclusion would adversely affect the marketing of the
securities to be sold by the Company therein; provided, however, that such number
of shares of Restricted Stock shall not be reduced if any shares are to be included in such
underwriting for the account of any person other than requesting holders of Restricted Stock.



     (b) Following receipt of any notice under this Section 2, the Company shall immediately
notify all holders of Restricted Stock from whom notice has not been received and shall use its
best efforts to register under the Securities Act, for public sale in accordance with the method of
disposition specified in such notice from requesting holders, the number of shares of Restricted
Stock specified in such notice (and in all notices received by the Company from other holders



-3-









 





within 30 days after the giving of such notice by the Company). If such method of disposition
shall be an underwritten public offering, the holders of a majority of the shares of Restricted
Stock to be sold in such offering may designate the managing underwriter of such offering, subject
to the approval of the Company, which approval shall not be unreasonably withheld or delayed. The
Purchasers shall have an unlimited number of demand registrations pursuant to this Section 2,
provided, however, that the Company shall not be obligated to effect more than two
such registrations in any twelve month period, provided, further, that such
obligation shall be deemed satisfied only when a registration statement covering all shares of
Restricted Stock specified in notices received as aforesaid, for sale in accordance with the method
of disposition specified by the requesting holders, shall have become effective and, if such method
of disposition is a firm commitment underwritten public offering, all such shares shall have been
sold pursuant thereto.



     (c) From and after the date hereof, the Company shall use its commercially reasonable efforts
to qualify under the provisions of the Securities Act, and thereafter, to continue to qualify at
all times, for registration on Form S-3 or any successor thereto. Demand registrations pursuant to
this Section 2 shall be on Form S-3 or any similar short-form registration statement, if available.
In the event the Company fails to qualify, the Company shall be required to effect demand
registrations pursuant to this Section 2 on Form S-1 or any successor thereto to the same extent as
the Company would be required to effect demand registrations on Form S-3.



     (d) The Company may postpone for a period of up to 45 days the filing of any registration
requested pursuant to this Section 2 if the Board of Directors of the Company in good faith
determines that such registration would require the public disclosure of any plan, proposal or
agreement by the Company with respect to any financing, acquisition, recapitalization,
reorganization or other material transaction, the disclosure of which would be materially adverse
to the Company, and such determination is evidenced by a board vote included in the minutes of the
meetings of the Company’s Board of Directors; provided, however, that the Company
may not exercise such right of postponement more frequently than one time in any 12 month period
and shall not register any securities for its own account or that of any other stockholder during
such 45 day period (except with respect to registration statements on Forms S-4, S-8 or another
form not available for registering the Restricted Stock for sale to the public).



     (e) The Company shall be entitled to include in any registration statement referred to in
this Section 2, for sale in accordance with the method of disposition specified by the requesting
holders, shares of Common Stock to be sold by the Company for its own account (to the extent that
the inclusion of such shares by the Company shall not adversely affect the offering), and shall not
be entitled to include shares held by any persons other than the holders of Restricted Stock.



     3. Piggyback Registration Rights. If the Company at any time (other than pursuant to
Section 2) proposes to register any of its securities under the Securities Act for sale to the
public, whether for its own account or for the account of other security holders or both (except
with



-4-









 




respect to registration statements on Forms S-4, S-8 or another form not available for
registering the Registrable Stock for sale to the public), each such time it will give prompt
written notice to all holders of outstanding Registrable Stock of its intention to do so. Upon the
written request of any such holder, received by the Company within 30 days after the giving of any
such notice by the Company, to register any of its Registrable Stock, the Company will use its best
efforts to cause the Registrable Stock as to which registration shall have been so requested to be
included in the securities to be covered by the registration statement proposed to be filed by the
Company, all to the extent required to permit the sale or other disposition by the holder of such
Registrable Stock so registered. In the event that any registration pursuant to this Section 3
shall be, in whole or in part, an underwritten public offering of Common Stock, the number of
shares of Registrable
Stock to be included in such an underwriting may be reduced if and to the extent that the
managing underwriter shall be of the opinion that such inclusion would adversely affect the
marketing of the securities to be sold by the Company therein. In the event that the managing
underwriter on behalf of all underwriters limits the number of shares to be included in a
registration pursuant to this Section 3, or shall otherwise require a limitation of the number of
shares to be included in the registration, then the Company will include in such registration:





	 	(i)	 	first, securities proposed by the Company to be sold for its own account;
	 
	 	(ii)	 	second, shares of Restricted Stock requested to be included by holders pursuant to this
Section 3;
	 
	 	(iii)	 	third, shares of Registrable Common Stock requested to be included by holders pursuant
to this Section 3; and
	 
	 	(iv)	 	fourth, securities requested to be included by any other holders,




provided, however, that such number of shares of Registrable Stock shall not be
reduced if any shares are to be included in such underwriting for the account of any person other
than the Company or requesting holders of Registrable Stock; and provided further,
however, that no event shall the Registrable Stock requested to be included by holders
pursuant to this Section 3 constitute less than thirty percent (30%) of all share to be registered
in such registration (in such event, the Company agrees to reduce the shares of Common Stock it
proposes to register for its own account or the account of holders initially requesting or
demanding registration in order to assure that such Registrable Stock constitute at least thirty
percent (30%) of the shares to be registered). The securities to be included in any such
registration pursuant to clause (ii) or (iii) above shall be allocated on a pro rata basis among
the requesting holders based upon the number of shares of Restricted Stock or Registrable Common
Stock, as the case may be, held by such holders. Notwithstanding the foregoing provisions, the
Company may withdraw any registration statement referred to in this Section 3 without thereby
incurring any liability to the holders of Registrable Stock.




-5-









 








     4. Registration Procedures. If and whenever the Company is required by the provisions
of Sections 2 or 3 to use its best efforts to effect the registration of any shares of Registrable
Stock under the Securities Act, the Company will, as expeditiously as possible:



          (a) prepare and promptly, and in any event within 30 days after the request for registration
has been delivered to the company, file with the Commission a registration statement with respect
to such securities and use its best efforts to cause such registration statement to become and
remain effective for the period of the distribution contemplated thereby (determined as hereinafter
provided) or in the case of a registration requested to be a “shelf”, for as long as requested to
the extent permitted by applicable law;




          (b) prepare and file with the Commission such amendments and supplements to such registration
statement and the prospectus used in connection therewith as may be necessary to keep such
registration statement effective for the period specified in paragraph (a) above and comply with the provisions of the Securities Act with respect to the disposition of all
Registrable Stock covered by such registration statement in accordance with the sellers’ intended
method of disposition set forth in such registration statement for such period;




          (c) furnish to each seller of Registrable Stock and to each underwriter such number of copies
of the registration statement and the prospectus included therein (including each preliminary
prospectus) as such persons reasonably may request in order to facilitate the public sale or other
disposition of the Registrable Stock covered by such registration statement;




          (d) use its best efforts to register or qualify the Registrable Stock covered by such
registration statement under the securities or “blue sky” laws of such jurisdictions as the sellers
of Registrable Stock or, in the case of an underwritten public offering, the managing underwriter
reasonably shall request, provided, however, that the Company shall not for any
such purpose be required to qualify generally to transact business as a foreign corporation in any
jurisdiction where it is not so qualified or to consent to general service of process in any such
jurisdiction;




          (e) use its best efforts to list the Registrable Stock covered by such registration statement
with any securities exchange on which the Common Stock of the Company is then listed;




          (f) provide a transfer agent and registrar for all such Registrable Stock not later than the
effective date of such registration statement;




          (g) immediately notify each seller of Registrable Stock and each underwriter under such
registration statement, at any time when a prospectus relating thereto is required to be delivered
under the Securities Act, of the happening of any event as a result of which the prospectus
contained in such registration statement, as then in effect, includes an untrue statement of a
material fact or omits to state a material fact required to be stated therein or necessary to make
the statements therein not misleading in light of the circumstances then existing, and at the
request of any such seller prepare and furnish to such seller a reasonable




-6-









 







number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter
delivered to the purchasers of such Registrable Stock, such prospectus shall not include an untrue
statement of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading in the light of the circumstances then
existing;




          (h) if the offering is underwritten and at the request of any seller of Registrable Stock, use
its best efforts to furnish on the date that Registrable Stock is delivered to the underwriters for
sale pursuant to such registration: (i) an opinion dated such date of counsel representing the
Company for the purposes of such registration, addressed to the underwriters and to such seller,
stating that such registration statement has become effective under the Securities Act and that (A)
to the best knowledge of such counsel, no stop order suspending the effectiveness thereof has been
issued and no proceedings for that purpose have been instituted or are pending or contemplated
under the Securities Act, (B) the registration statement, the related prospectus and each amendment
or supplement thereof comply as to form in all material respects with the requirements of the Securities Act (except that such counsel need not express any
opinion as to financial statements contained therein) and (C) to such other effects as reasonably
may be requested by counsel for the underwriters or by such seller or its counsel, and (ii) a
letter dated such date from the independent public accountants retained by the Company, addressed
to the underwriters and to such seller, stating that they are independent public accountants within
the meaning of the Securities Act and that, in the opinion of such accountants, the financial
statements of the Company included in the registration statement or the prospectus, or any
amendment or supplement thereof, comply as to form in all material respects with the applicable
accounting requirements of the Securities Act, and such letter shall additionally cover such other
financial matters (including information as to the period ending no more than five business days
prior to the date of such letter) with respect to such registration as such underwriters or sellers
reasonably may request;




          (i) use its best efforts to cooperate with the sellers in the disposition of the Registrable
Stock covered by such registration statement, including without limitation in the case of an
underwritten offering causing key executives of the Company and its subsidiaries to participate
under the direction of the managing underwriter in a “road show” scheduled by such managing
underwriter in such locations and of such duration as in the judgment of such managing underwriter
are appropriate for such underwritten offering;




          (j) in connection with the preparation and filing of each registration statement registering
Registrable Stock under the Securities Act, and before filing any such registration statement or
any other document in connection therewith, give the participating holders and their underwriters,
if any, and their respective counsel and accountants, the opportunity to participate in the
preparation of such registration statement, each prospectus included therein or filed with the
Commission, each amendment thereof or supplement thereto and any related underwriting agreement or
other document to be filed, and give each of the aforementioned persons such access to its books
and records, including all financial and other records, pertinent corporate




-7-









 







documents and properties of the Company, and such opportunities to discuss the business of the Company with its
officers, directors and employees and the independent public accountants who have certified its
financial statements as shall be necessary, in the opinion of such holders, underwriters, counsel
or accountants, to conduct a reasonable investigation within the meaning of the Securities Act; and




          (k) otherwise use its best efforts to comply with the Securities Act, the Exchange Act and any
other applicable rules and regulations of the Commission, and make available to its securities
holders, as soon as reasonably practicable, an earning statement covering the period of at least 12
months after the effective date of such registration statement, which earning statement shall
satisfy Section 11(a) of the Securities Act and any applicable regulations thereunder, including
Rule 158.




     For purposes of Sections 4(a) and 4(b) and of Section 2(d), the period of distribution of
Registrable Stock in a firm commitment underwritten public offering shall be deemed to extend until
each underwriter has completed the distribution of all securities purchased by it, and the period
of distribution of Registrable Stock in any other registration shall be deemed to extend until the earlier of the sale of all Registrable Stock covered thereby and 120 days after the
effective date thereof or in the case of a registration requested to be a “shelf”, for as long as
requested to the extent permitted by applicable law.



     In connection with each registration hereunder, the sellers of Registrable Stock will furnish
to the Company in writing such information with respect to themselves and the proposed distribution
by them as reasonably shall be necessary in order to assure compliance with federal and applicable
state securities laws.



     In connection with each registration pursuant to Sections 2 or 3 covering an underwritten
public offering, the Company and each seller agree to enter into a written underwriting agreement
with the managing underwriter selected in the manner herein provided in such form and containing
such provisions as are customary in the securities business for such an arrangement between such
underwriter and companies of the Company’s size and investment stature; provided,
however, that (i) the representations and warranties by, and the other agreements on the
part of, the Company to and for the benefit of the underwriters shall also be made to and for the
benefit of such sellers of Registrable Stock, and (ii) no seller shall be required to make, and the
Company shall use its best efforts to ensure that no underwriter requires any seller to make, any
representations and warranties, to or agreements with any underwriter in a registration effected
pursuant to Sections 2 or 3 other than customary representations, warranties and agreements
relating to such seller’s title to Registrable Stock and authority to enter into the underwriting
agreement.



     5. Expenses. All expenses incurred by the Company in complying with Sections 4 and 5,
including, without limitation, all registration and filing fees, printing expenses, fees and
disbursements of counsel and independent public accountants for the Company, fees and expenses
(including counsel fees) incurred in connection with complying with state securities or



-8-









 




“blue sky” laws, fees of the National Association of Securities Dealers, Inc., transfer taxes, fees of
transfer agents and registrars, costs of insurance and fees and disbursements of one counsel for
the sellers of Registrable Stock (which fees and disbursements of the one counsel to the sellers
shall not exceed $50,000), but excluding any Selling Expenses, are called “Registration Expenses.”
All underwriting discounts and selling commissions applicable to the sale of Restricted Stock are
called “Selling Expenses.”




     The Company will pay all Registration Expenses in connection with each registration statement
under Sections 2 or 3. All Selling Expenses in connection with each registration statement under
Sections 2 or 3 shall be borne by the participating sellers in proportion to the number of shares
sold by each, or by such participating sellers as they may agree.



     6. Indemnification and Contribution. (a) In the event of a registration of any of
the Registrable Stock under the Securities Act pursuant to Sections 2 or 3, the Company will
indemnify and hold harmless each seller of Registrable Stock thereunder, each underwriter of such
Registrable Stock thereunder and each other person, if any, who controls or is alleged to control
such seller or underwriter within the meaning of the Securities Act, against any losses, claims,
damages or liabilities, joint or several, to which such seller, underwriter or controlling person
may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages
or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement
or alleged untrue statement of any material fact contained in any registration statement under
which such Registrable Stock were registered under the Securities Act pursuant to Sections 2 or 3,
any preliminary prospectus or final prospectus contained therein, or any amendment or supplement
thereof, or arise out of or are based upon the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements therein not
misleading, or arises out of or are based upon any violation or alleged violation of any federal,
state or other law, rule or regulation relating to any action or inaction in connection therewith,
and will reimburse each such seller, each such underwriter and each such controlling person for any
legal or other expenses reasonably incurred by them in connection with investigating or defending
any such loss, claim, damage, liability or action, provided, however, that the
Company will not be liable to any such indemnitee if and to the extent that any such loss, claim,
damage or liability arises solely out of or is based solely upon an untrue statement or alleged
untrue statement or omission or alleged omission so made in conformity with information with
respect to such indemnitee furnished by such indemnitee in writing specifically for use in such
registration statement or prospectus. The indemnities of the Company contained in this Section 6
shall remain in full force and effect regardless of any investigation made by or on behalf of such
indemnified person and shall survive any transfer of Registrable Stock.



     (b) In the event of a registration of any of the Registrable Stock under the Securities Act
pursuant to Sections 2 or 3, each seller of such Registrable Stock thereunder, severally and not
jointly, will indemnify and hold harmless the Company, each person, if any, who controls the
Company within the meaning of the Securities Act, each officer of the Company who signs the



-9-









 




registration statement, each director of the Company, each underwriter and each person who controls
any underwriter within the meaning of the Securities Act, against all losses, claims, damages or
liabilities, joint or several, to which the Company or such officer, director, underwriter or
controlling person may become subject under the Securities Act or otherwise, insofar as such
losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based
upon any untrue statement or alleged untrue statement of any material fact contained in the
registration statement under which such Registrable Stock was registered under the Securities Act
pursuant to Sections 2 or 3, any preliminary prospectus or final prospectus contained therein, or
any amendment or supplement thereof, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the
statements therein not misleading, and will reimburse the Company and each such officer, director,
underwriter and controlling person for any legal or other expenses reasonably incurred by them in
connection with investigating or defending any such loss, claim, damage, liability or action,
provided, however, that such seller will be liable hereunder in any such case if
and only to the extent that any such loss, claim, damage or liability arises solely out of or is
based solely upon an untrue statement or alleged untrue statement or omission or alleged omission
made in reliance upon and in conformity with information pertaining to such seller, as such,
furnished in writing to the Company by such seller specifically for use in such registration
statement or prospectus, and provided, further, however, that the liability
of each seller hereunder shall be limited to the proportion of any such loss, claim, damage,
liability or expense which is equal to the proportion that the public offering price of the shares
sold by such seller under such registration statement bears to the total public offering price of all securities sold thereunder, but not in any
event to exceed the net proceeds received by such seller from the sale of Registrable Stock covered
by such registration statement (after deduction of all underwriters’ discounts and commissions and
all other expenses paid by such seller in connection with the registration in question). Such
indemnity shall remain in full force and effect regardless of any investigation made by or on
behalf of the Company or any such director, officer, underwriter or controlling person and shall
survive any transfer of Registrable Stock.




     (c) Promptly after receipt by an indemnified party hereunder of notice of the commencement of
any action, such indemnified party shall, if a claim in respect thereof is to be made against the
indemnifying party hereunder, notify the indemnifying party in writing thereof, but the omission so
to notify the indemnifying party shall not relieve it from any liability which it may have to such
indemnified party other than under this Section 6 and shall only relieve it from any liability
which it may have to such indemnified party under this Section 6 if and to the extent the
indemnifying party is prejudiced by such omission. In case any such action shall be brought
against any indemnified party and it shall notify the indemnifying party of the commencement
thereof, the indemnifying party shall be entitled to participate in and, to the extent it shall
wish, to assume and undertake the defense thereof with counsel satisfactory to such indemnified
party, and, after notice from the indemnifying party to such indemnified party of its election so
to assume and undertake the defense thereof, the indemnifying party shall not be liable to such
indemnified party under this Section 6 for any legal expenses subsequently incurred by such
indemnified party in connection with the defense thereof other than reasonable



-10-









 




costs of investigation and of liaison with counsel so selected, provided, however, that, if
the defendants in any such action include both the indemnified party and the indemnifying party and
the indemnified party shall have reasonably concluded that there may be reasonable defenses
available to it which are different from or additional to those available to the indemnifying party
or if the interests of the indemnified party reasonably may be deemed to conflict with the
interests of the indemnifying party, the indemnified party shall have the right to select a
separate counsel and to assume such legal defenses and otherwise to participate in the defense of
such action, with the expenses and fees of such separate counsel and other expenses related to such
participation to be reimbursed by the indemnifying party as incurred. No indemnifying party, in
the defense of any such claim or litigation, shall, except with the consent of each indemnified
party, consent to entry of any judgment or enter into any settlement unless such judgment or
settlement includes as an unconditional term thereof the giving by the claimant or plaintiff to
such indemnified party of a release from all liability in respect to such claim or litigation,
includes only money damages (as opposed to equitable relief) and does not include any statement as
to the fault or culpability of such indemnified party.




     (d) In order to provide for just and equitable contribution to joint liability under the
Securities Act in any case in which either (i) any holder of Registrable Stock exercising rights
under this Agreement, or any controlling person of any such holder, makes a claim for
indemnification pursuant to this Section 6 but it is judicially determined (by the entry of a final
judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the
denial of the last right of appeal) that such indemnification may not be enforced in such case
notwithstanding the fact that this Section 6 provides for indemnification in such case, or (ii)
contribution under the Securities Act may be required on the part of any such selling holder
or any such controlling person in circumstances for which indemnification is provided under this
Section 6; then, and in each such case, the Company and such holder will contribute to the
aggregate losses, claims, damages or liabilities to which they may be subject (after contribution
from others) in such proportion so that such holder is responsible for the portion represented by
the percentage that the aggregate public offering price of its Registrable Stock offered by the
registration statement bears to the aggregate public offering price of all securities offered by
such registration statement, and the Company is responsible for the remaining portion;
provided, however, that, in any such case, (A) no such holder will be required to
contribute any amount in excess of the net proceeds received by it from the sale of all such
Restricted Stock offered by it pursuant to such registration statement (after deduction of all
underwriters’ discounts and commissions and all other damages and expenses paid by such seller in
connection with the registration in question); and (B) no person or entity guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to
contribution from any person or entity who was not guilty of such fraudulent misrepresentation.



     7. Changes in Common Stock or Preferred Stock. If, and as often as, there is any
change in the Common Stock or the Series C Preferred Stock by way of a stock split, stock dividend,
combination or reclassification, or through a merger, consolidation, reorganization or
recapitalization, or by any other means, appropriate adjustment shall be made in the provisions



-11-









 




hereof so that the rights and privileges granted hereby shall continue with respect to the Common
Stock or the Series C Preferred Stock as so changed.




     8. Rule 144 Reporting. With a view to making available the benefits of certain rules
and regulations of the Commission which may at any time permit the sale of the Restricted Stock to
the public without registration, the Company agrees to:



          (a) make and keep public information available, as those terms are understood and defined in
Rule 144 under the Securities Act;



          (b) use its best efforts to file with the Commission in a timely manner all reports and other
documents required of the Company under the Securities Act and the Exchange Act; and



          (c) furnish to each holder of Restricted Stock forthwith upon request a written statement by
the Company as to its compliance with the reporting requirements of such Rule 144 and of the
Securities Act and the Exchange Act, a copy of the most recent annual or quarterly report of the
Company, and such other reports and documents so filed by the Company as such holder may reasonably
request in availing itself of any rule or regulation of the Commission allowing such holder to sell
any Restricted Stock without registration.



     9. Purchase Rights. The Company agrees as follows:



          (a) Subsequent Offerings. Each Purchaser shall have a right of first refusal (the
“Purchase Rights”) to purchase its Pro Rata Share of all Equity Securities other than the Equity
Securities excluded by Section 9(e) hereof.



          (b) Exercise of Rights.



               (i) If the Company proposes to issue any Equity Securities, it shall give each Purchaser
written notice of its intention, describing the Equity Securities, the price and the terms and
conditions upon which the Company proposes to issue the same. Each Purchaser shall have thirty
(30) days from the giving of such notice to agree to purchase its Pro Rata Share of the Equity
Securities for the price and upon the terms and conditions specified in the notice by giving
written notice to the Company (the “Company Notice”) and stating therein the quantity of such
Equity Securities to be purchased.



               (ii) If not all of the Purchasers elect to purchase their Pro Rata Share of the Equity
Securities, then the Company shall promptly notify in writing the Purchasers who have elected to
purchase their full Pro Rata Share of such Equity Securities and shall offer such Purchasers (the
“Purchasing Investors”) the right to acquire such unsubscribed shares. The Purchasing Investors
shall have fifteen (15) days after receipt of such notice to notify the Company (the “Purchasing
Investor Notice”) of their election to purchase all or a portion thereof of the unsubscribed
shares. If the Purchasing Investors have, in the aggregate elected to



-12-









 




purchase more than the number of unsubscribed shares being offered in such notice, then the unsubscribed shares shall be
allocated according to each Purchasing Investor’s Pro Rata Share up to the number of unsubscribed
shares set forth in the notice to the Purchasing Investors, provided that for
purposes of this Section 9(b)(ii), the numerator in clause (a) of the defined term “Pro Rata Share”
shall be the number of shares of Common Stock beneficially owned by such Purchasing Investor plus
the number of shares of Common Stock issuable upon conversion of the Series C Preferred Stock
beneficially owned by such Purchasing Investor immediately prior to the proposed issuance and the
denominator in clause (b) of the defined term “Pro Rata Share” shall be the total number of shares
of Common Stock beneficially owned by, and the number of shares of Common Stock issuable upon
conversion of the Series C Preferred Stock beneficially owned by all the Purchasing Investors
immediately prior to the proposed issuance. The Purchasing Investors shall then effect the purchase
of the Equity Securities at the closing of the issuance of Equity Securities described in the
notice delivered by the Company pursuant to Section 9(b)(i). On the date of such closing, the
Company shall deliver to the Purchasing Investors the certificates representing the Equity
Securities to be purchased by the Purchasing Investors, each certificate to be properly endorsed
for transfer, and at such time, the Purchasing Investors shall pay the purchase price for the
Equity Securities.




          (c) Issuance of Equity Securities to Other Persons. If the Purchasers fail to
exercise in full their Purchase Rights, the Company shall have sixty (60) days thereafter to sell
the Equity Securities in respect of which the Purchasers’ rights were not exercised, at a price and
upon general terms and conditions no more favorable to the purchasers thereof than specified in the
Company’s notice to the Purchasers pursuant to Section 9(b)(i) hereof. If the Company has not sold such Equity Securities within such sixty (60) days, the Company shall not thereafter
issue or sell any Equity Securities, without first again complying with this Section 9.



          (d) Transfer of Purchase Rights. The Purchase Rights of each Purchaser under this
Section 9 may be transferred to any Purchaser Permitted Transferee; provided, that any such
Purchaser Permitted Transferee shall furnish the Company a written agreement, satisfactory to the
Company, to be bound by and comply with all provisions of this Agreement as if such Purchaser
Permitted Transferee were a Purchaser.



          (e) Excluded Securities. The Purchase Rights established by this Section 9 shall have
no application to any of the following Equity Securities (collectively, the “Excluded Securities”):



               (i) any Common Stock issued upon conversion of the Series C Preferred Stock;



               (ii) shares of Common Stock (and/or options, warrants or other Common Stock purchase rights
issued pursuant to such options, warrants or other rights), as appropriately adjusted for stock
dividends, stock splits, combinations, recapitalizations or other similar events affecting the
Common Stock, issued to employees, officers or directors of, or consultants or



-13-









 




advisors to the Company or any subsidiary, pursuant to stock purchase or stock option plans or other equity
compensation arrangements that are approved by the Board;




               (iii) any Common Stock issued upon exercise of options, warrants or convertible securities
outstanding as of the date of this Agreement;



               (iv) any Common Stock issued as consideration in connection with or relating to any permitted
acquisitions, mergers or strategic partnership transactions (other than transactions entered into
primarily for equity financing purposes) that have been approved by the Board; or



               (v) any Equity Securities designated as Excluded Securities by holders of a majority of the
Series C Preferred Stock then outstanding; provided, however, that no holder of Series C Preferred
Stock or any of its Affiliates may purchase any such Equity Securities designated as Excluded
Securities unless all holders of Series C Preferred Stock are able to participate based on their
relative Pro Rata Share.



     10. Miscellaneous.



          (a) Successors and Assigns. All covenants and agreements contained in this Agreement
by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective
successors and assigns of the parties hereto (including without limitation transferees of any
Preferred Shares or Restricted Stock, but not transferees of any Registrable Common Stock), whether
so expressed or not, provided, however, that the rights conferred herein on the
holders of Preferred Shares or Restricted Stock to require the registration of shares of Restricted
Stock or the rights under Section 9 above shall only inure to the benefit of a transferee of
Preferred Shares or Restricted Stock if (i) there is transferred to such transferee shares
representing at least five percent (5%) of the outstanding shares of Restricted Stock (assuming the conversion of all
Preferred Shares into Restricted Stock) or (ii) such transferee is a Purchaser Permitted Transferee
or a partner, shareholder or affiliate of a party hereto. Transfer of registration rights to a
Purchaser Permitted Transferee or to a partner, member or shareholder of any Purchaser will be
without restriction as to minimum shareholding. Any transferee to whom rights under this
Agreement are transferred shall (i) as a condition to such transfer, deliver to the Company a
written instrument by which such transferee agrees to be bound by the obligations imposed upon
holders under this Agreement to the same extent as if such transferee were a holder under this
Agreement and (ii) be deemed to be a holder hereunder.



          (b) Notices. All notices, requests, consents and other communications hereunder shall
be in writing and shall be delivered in person, mailed by certified or registered mail, return
receipt requested, or sent by telecopier or telex, addressed as follows:



               (i) if to the Company or any Purchaser, at the address of such party set forth in the Purchase
Agreement;




-14-










 





               (ii) if to any Stockholder, at the address of such party set forth on the signature page
to this Agreement;



               (iii) if to any subsequent holder of Preferred Shares or Restricted Stock, to it at such
address as may have been furnished to the Company in writing by such holder;


or, in any case, at such other address or addresses as shall have been furnished in writing to the
Company (in the case of a holder of Preferred Shares, Restricted Stock or Registrable Common Stock)
or to the holders of Preferred Shares, Restricted Stock or Registrable Common Stock (in the case of
the Company) in accordance with the provisions of this paragraph.




          (c) Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of New York, without regard to its conflict of law principles.



          (d) Amendments, Waivers and Consents. This Agreement may not be amended or modified,
and no provision hereof may be waived, without the written consent of the Company and the holders
of at least seventy-five percent (75%) of the outstanding shares of Restricted Stock (assuming the
conversion of all Preferred Shares into Restricted Stock); provided, however, that,
without a holder’s consent, any such amendment or waiver shall not treat such holder differently
from any other holder. The Company shall deliver copies of such consent to any holders who did not
execute the same. Neither this Agreement, nor any provision hereof, may be changed, waived,
discharged or terminated orally or by course of dealing, but only by an instrument in writing.



          (e) No Waivers. No failure or delay by any party in exercising any right, power or
privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise
thereof preclude any other or further exercise thereof or the exercise of any other right, power or
privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any
rights or remedies provided by law.



          (f) Headings. The headings of the Sections and paragraphs of this Agreement have been
inserted for convenience of reference only and do not constitute a part of this Agreement.



          (g) Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same
instrument. Any person who, after the date hereof, acquires shares of Preferred Stock shall become
a party to this Agreement as a “Purchaser” and a holder of “Restricted Stock” for all purposes
hereunder, all upon execution by such person and the Company of a counterpart of this Agreement.



          (h) Termination of Registration Rights. The obligations of the Company to register
shares of Restricted Stock under Sections 2 or 3 shall terminate as to each holder of



- 15 -









 







Restricted Stock on the date such holder of Restricted Stock (or Preferred Shares which are convertible into
shares of Restricted Stock) may immediately sell or distribute all of the shares of Restricted
Stock (including shares of Restricted Stock issuable upon conversion of such holder’s Preferred
Shares) held by such holder pursuant to Rule 144(k) under Securities Act and such holder owns less
than one percent (1%) of the Company’s outstanding Common Stock (on an as-converted basis).



          (i) Additional Registration Rights. The Company shall not grant to any additional
registration rights after the date hereof without the consent of the Purchasers holding at least
seventy-five percent (75%) of the Restricted Stock unless such registrations rights are subordinate
in all respects to the Purchasers’ rights contained herein.



          (j) Company Registration. In the event that the registration requirements under the
Securities Act are amended or eliminated to accommodate a “Company registration” or similar
approach, this Agreement shall be deemed amended to the extent necessary to reflect such changes
and the intent of the parties hereto with respect to the benefits and obligations of the parties,
and in such connection, the Company shall use reasonable efforts to provide holders of Restricted
Stock equivalent benefits to those provided under this Agreement.



          (k) Cumulative Remedies. None of the rights, powers or remedies conferred upon the
Purchasers on the one hand or the Company on the other hand shall be mutually exclusive, and each
such right, power or remedy shall be cumulative and in addition to every other right, power or
remedy, whether conferred by this Agreement or now or hereafter available at law, in equity, by
statute or otherwise. In addition to being entitled to exercise all rights provided herein or
granted by law, including recovery of damages, each of the Purchasers and the Company will be
entitled to specific performance under this Agreement. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained
in this Agreement and hereby agrees to waive and not to assert in any action for specific
performance of any such obligation the defense that a remedy at law would be adequate.



          (l) Jurisdiction. Any suit, action or proceeding seeking to enforce any provision of,
or based on any matter arising out of or in connection with, this Agreement or the transactions
contemplated hereby shall be brought in any federal or state court located in the State of New
York, and each of the parties hereby consents to the jurisdiction of such courts (and of the
appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably
waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to
the laying of the venue of any such suit, action or proceeding in any such court or that any such
suit, action or proceeding which is brought in any such court has been brought in an inconvenient
forum. Process in any such suit, action or proceeding may be served on any party anywhere in the
world, whether within or without the jurisdiction of any such court. Without limiting the
foregoing, each party agrees that service of process on such party as provided in Section 10(l)
shall be deemed effective service of process on such party.



- 16 -









 





          (m) Waiver of Jury Trial. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT
BE WAIVED, THE INVESTORS AND THE COMPANY HEREBY WAIVE, AND COVENANT THAT NEITHER THE COMPANY NOR
THE INVESTORS WILL ASSERT, ANY RIGHT TO TRIAL BY JURY ON ANY ISSUE IN ANY PROCEEDING, WHETHER AS
PLAINTIFF, DEFENDANT OR OTHERWISE, IN RESPECT OF ANY ISSUE, CLAIM, DEMAND, ACTION OR CAUSE OF
ACTION ARISING OUT OF OR BASED UPON THIS AGREEMENT, ANY OTHER AGREEMENT OR THE SUBJECT MATTER
HEREOF OR THEREOF OR IN ANY WAY CONNECTED WITH, RELATED OR INCIDENTAL TO THE DEALINGS OF THE
INVESTORS AND THE COMPANY HEREUNDER OR THEREUNDER, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER
ARISING AND WHETHER IN TORT OR CONTRACT OR OTHERWISE. The Company acknowledges that it has been
informed by the Purchasers and Stockholders that the provisions of this Section 10(m) constitute a
material inducement upon which the Purchasers are relying and will rely in entering into this
Agreement. Any Purchaser, Stockholder or the Company may file an original counterpart or a copy of
this Section 10(m) with any court as written evidence of the consent of the Purchasers,
Stockholders and the Company to the waiver of the right to trial by jury.



          (n) Severability. If any provision of this Agreement shall be held to be illegal,
invalid or unenforceable, such illegality, invalidity or unenforceability shall attach only to such
provision and shall not in any manner affect or render illegal, invalid or unenforceable any other
provision of this Agreement, and this Agreement shall be carried out as if any such illegal,
invalid or unenforceable provision were not contained herein.



[Remainder of Page Intentionally Left Blank]




- 17 -









 








     IN WITNESS WHEREOF, the parties hereto have caused this Investor Rights Agreement to be duly
executed as of the day and year first above written.



	 	 	 	 	 
	 	THE COMPANY



THE PRINCETON REVIEW, INC.

 	 
	 	By:  	/s/
Michael J. Perik	 
	 	 	Name:  	Michael J. Perik 	 
	 	 	Title:  	Chief Executive Officer 	 
	 



Signature Page to Investor Rights Agreement




 









 









     IN WITNESS WHEREOF, the parties hereto have caused this Investor Rights Agreement to be duly
executed as of the day and year first above written.



	 	 	 	 	 
	 	THE PURCHASERS



BAIN CAPITAL VENTURE FUND 2007, L.P.

By: Bain Capital Venture Partners, L.P., its general partner

By: Bain Capital Investors, LLC, its general partner

 	 
	 	By:  	/s/ Michael A. Krupka	 
	 	 	Name:  	Michael A. Krupka	 
	 	 	Title:  	Authorized Person 	 
	 
	 	BCIP VENTURE ASSOCIATES

By: Bain Capital Investors, LLC, its managing partner

By: Bain Capital Venture Investors, LLC,
 its Attorney-in-fact

 	 
	 	By:  	/s/ Michael A. Krupka	 
	 	 	Name:  	Michael A. Krupka	 
	 	 	Title:  	Managing Director 	 
	 
	 	BCIP VENTURE ASSOCIATES-B

By: Bain Capital Investors, LLC, its managing partner

By: Bain Capital Venture Investors, LLC,
 its Attorney-in-fact

 	 
	 	By:  	/s/ Michael A. Krupka	 
	 	 	Name:  	Michael A. Krupka	 
	 	 	Title:  	Managing Director 	 
	 
	 	RGIP, LLC

 	 
	 	By:  	/s/ Alfred O. Rose	 
	 	 	Name:  	Alfred O. Rose	 
	 	 	Title:  	Managing Member	 
	 



Signature Page to Investor Rights Agreement




 









 








	 	 	 	 	 
	 	PRIDES CAPITAL FUND I LP

By: Prides Capital Partners, L.L.C., its general partner

 	 
	 	By:  	/s/
Henry J. Lawler, Jr.	 
	 	 	Name:  	Henry J. Lawler, Jr.	 
	 	 	Title:  	Managing Member of the General Partner	 
	 



Signature Page to Investor Rights Agreement




 









 










     IN WITNESS WHEREOF, the parties hereto have caused this Investor Rights Agreement to be duly
executed as of the day and year first above written.



	 	 	 	 	 
	 	THE STOCKHOLDERS 

 	 
	 	By:  	/s/
Michael J. Perik 	 
	 	 	Name:  	Michael J. Perik 	 
	 	 	 	 
	 
	 	Address:

              
              
              
              
              
    

              
             
              
              
               
    

               
              
               
               
               

 	 



Signature Page to Investor Rights Agreement